Bioventus saw no growth in patent filings and highest growth of 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Bioventus‘s patent filings and grants. Buy the databook here.
Bioventus has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 33% grants. The United States(US), China(CN), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Bioventus is filings its patents. Among the top granted patent authorities, Bioventus has 33% of its grants in United States(US), 17% in China(CN) and 17% in European Patent Office(EPO).
Olympus could be the strongest competitor for Bioventus
In terms of grant share, Bioventus stands in fifth position among its competitors. Olympus and Bioventus secured the top positions according to recent patent publication data.
Patents related to healthtech and industrial automation lead Bioventus's portfolio
Bioventus has the highest number of patents in healthtech followed by, industrial automation. For healthtech no patents were filed and 50% of patents were granted in Q2 2024.
General surgery devices related patents lead Bioventus portfolio followed by orthopedic devices, and spinal surgery
Bioventus has highest number of patents in general surgery devices followed by orthopedic devices, spinal surgery, forceps, and baseball. For general surgery devices, nearly 100% of patents were filed and 33% of patents were granted in Q2 2024.
For comprehensive analysis of Bioventus's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.